Importantly, the CD3ζ chain loss in T-cells of cancer patients is biologically significant, as it correlates with worse prognosis and shorter OS, as reported for OvCa33, head and neck cancer48, and breast cancer49. The gene discussed is CD247; the disease is cancer.